$DGX with a bullish outlook following its earnings #StocksThe PEAD projected a bullish outlook for NYSE:DGX after a positive under reaction following its earnings release placing the stock in drift A with an expected accuracy of 57.14%.
Key facts today
21,583.18
0.02 BRL
4.25 B BRL
46.21 B BRL
About Quest Diagnostics Incorporated
Sector
Industry
CEO
James E. Davis
Website
Headquarters
Secaucus
Founded
1967
ISIN
BRQ1UEBDR005
FIGI
BBG00RD63231
Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.
Is this a double bottom?I don't know either. But I've placed a stop buy order above the price - if it breaksout to the upside, I'll enter long.
Quest Diagnostics // Buy Future Dip Notes on how I personally use my charts/NFA:
Each level L1-L3 and TP1-TP3 (Or S1-S3) has a deployment percentage. The idea is to flag these levels so I can buy 11% at L1 , 28% at L2 and if L3 deploy 61% of assigned dry powder. The same in reverse goes for TP. TP1: 61%, TP2:28% and TP3:11%. If chart
DGX Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
DGX PUT ideaDGX is :
Current price: 139,91
1- in descending triangle
2- Low volume
3- SMA 200 reacts as resistance along with the descending triangle
4- EBITDA in decline except for Q1 2023
=> Put options for January 2024 open. no SL.
Counter trade:
1- Analysts target: 145
2- OBV/AD are trending higher
3- PE
$DGX with a neutral outlook following its earnings #StocksThe PEAD projected a neutral outlook for $DGX after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 71.43%.
$DGX with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $DGX after a Positive Under reaction following its earnings release placing the stock in drift A with an expected accuracy of 25%.
Quest Diagnostic Incorporated – Rare Stock with 30% Upside OpporIf you like this idea, please don’t forget to Boost it.
Fundamental Indicators:
Sector – Healthcare
US Business Cycle Stage – late cycle, when this sector is favourable
Revenue – consistently growing for the past 5 years, with 9% average annual rate
Profits – explosive growth until
180 day MA ResistanceNYSE:DGX
Anticipating a pull back after the resistance shown at the 180 day MA on 3/18/22.
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
DGX.GL
Quest Diagnostics Incorporated 5.75% 30-JAN-2040Yield to maturity
6.00%
Maturity date
Jan 30, 2040
DGX4986719
Quest Diagnostics Incorporated 2.8% 30-JUN-2031Yield to maturity
5.51%
Maturity date
Jun 30, 2031
DGX4923784
Quest Diagnostics Incorporated 2.95% 30-JUN-2030Yield to maturity
5.40%
Maturity date
Jun 30, 2030
DGX5874569
Quest Diagnostics Incorporated 5.0% 15-DEC-2034Yield to maturity
5.38%
Maturity date
Dec 15, 2034
DGX5678099
Quest Diagnostics Incorporated 6.4% 30-NOV-2033Yield to maturity
5.22%
Maturity date
Nov 30, 2033
DGX.GJ
Quest Diagnostics Incorporated 6.95% 01-JUL-2037Yield to maturity
5.18%
Maturity date
Jul 1, 2037
DGX5874568
Quest Diagnostics Incorporated 4.625% 15-DEC-2029Yield to maturity
5.12%
Maturity date
Dec 15, 2029
DGX4807226
Quest Diagnostics Incorporated 4.2% 30-JUN-2029Yield to maturity
5.04%
Maturity date
Jun 30, 2029
DGX4366387
Quest Diagnostics Incorporated 3.45% 01-JUN-2026Yield to maturity
4.78%
Maturity date
Jun 1, 2026
Explore more bonds